Pregnant ewes were injected with either the antiprogesterone, RU 486 (4 mg kg\m=-\1body weight, i.m.; n = 5), 3000 iu relaxin (i.m.; n = 9), or diluent (n = 
Introduction
Relaxin is a peptide hormone produced in greatest concen¬ trations by female reproductive tissues, particularly during pregnancy (Anderson, 1987; Sherwood, 1988) . Maximum peri¬ pheral blood concentrations of relaxin occur a few hours before parturition in rats and pigs, but no similar evidence is available for sheep (Sherwood et al, 1980; Felder et al, 1986) . Low relaxin immunoreactivity has been reported in placental, endometrial and ovarian tissues (0.05-11.00 ng g_I) of ewes from day 21 to parturition, but no obvious trend was found throughout pregnancy (Renegar and Larkin, 1985; Wathes et al, 1988) .
Relaxin increases cervical compliance in oestrogen-primed ovariectomized ewes (Nemec et al, 1988) and reduces uterine contractility (Porter et al, 1981) , thus suggesting a role for this hormone in pregnancy.
Maintenance of pregnancy in mammals, including sheep, requires the binding of progesterone to its receptor in the uter¬ ine endometrium leading to the proliferation of the epithelial and vascular cells. A decrease in circulating progesterone con¬ centrations must precede induced or spontaneous parturition in ewes (Stabenfeldt el al, 1972; Ledger et al, 1985) , and this can be achieved by blocking progesterone synthesis with 3ß-hydroxysteroid dehydrogenase inhibitors (Taylor, 1987) . RU 486 (11 ß-[4-dimethyl-amino phenyl]l7ß-hydroxy-l7fX- [l-propynyl] estra-4,9-dien-3-one) is a 19-norsteroid with potent antiprogesterone and antiglucocorticoid activities (Baulieu, 1989) (Benhamou et al, 1992) . Relaxin administered to cattle late in pregnancy decreases circulating progesterone and also advances parturition (Musah et al, 1986; Bagna et al, 1991) and it decreases progesterone in cyclic ewes (Akinbami et al, 1990 50, 100, 200 and 400 µ and showed parallelism in a dose-dependent manner with porcine relaxin added to plasma from ovariectomized ewes. Intra-and interassay coefficients of variation were 5.6% (n = 3) and 9.7% ( = 3), respectively. The nonspecific binding of the assay was 2.08% (n = 3), and the maximum binding of the first antibody was 33%.
Progesterone was determined in 200 µ aliquots of plasma, as described by Musah et al (1986) , using the progesterone anti¬ body (Niswender, 1973 ively. The sensitivity of the assay was 0.25 ng ml"1. The nonspecific binding of all assays was 3.0% (n = 4) and the maximum antibody binding was 34.3% (n = 4). The overall extraction efficiency was 84.8% (n = 4) and the intra-and inter¬ assay coefficients of variation were 4.8% (n = 4) and 8.1%
(n = 4), respectively. The progesterone concentration averaged 11 + 0.6 ng ml-1 during the pretreatment period. During the post-treatment period, overall plasma progesterone concentrations were sig¬ nificantly lower in RU 486-(8 + 0.7 ng ml-1; < 0.05) and relaxin-(8 + 0.4 ng ml-1; < 0.05) groups compared with diluent-treated controls (11 + 0.6 ng ml-1; Fig. 1 (Fig. la) . Progesterone averaged 6ng ml-1 in the RU 486 treated ewes at induced lambing on day 145 compared with 11 ng ml-1 in the controls (P < 0.01) at that time. Up to day 147, progesterone was consistently lower (P < 0.05) in the relaxin-injected ewes than in the controls and then it decreased steadily until parturition occurred on days 149 and 150 in both groups (Fig. lb) . At parturition, progesterone averaged 4 ng ml 1 in relaxin-and diluent-treated ewes (Fig. lb) .
Immunoreactive relaxin plasma concentrations
In the control ewes, immunoreactive relaxin concentrations increased (P < 0.05) with advancing gestation, reaching a peak of 3.9 ng ml-1 on day 146 (Fig. 2) (Fig. 2) . Relaxin concentrations remained consist¬ ently less (P < 0.01) in the RU 486-treated group (0.5 ng ml-1) than in the controls (1.5 ng ml-1) from 5 days before and up to the day of parturition. During the overall post-treatment period, immunoreactive relaxin was lower (P < 0.05) after RU 486 (0.6 ± 0.03 ng 1) than after diluent treatment (1.2 ± 0.17 ng ml"1).
Relaxin i.m. injection abruptly increased (P < 0.01) the circu¬ lating relaxin concentration from 0.6 to 45 ng ml-1 on day 144 (Fig. 3b) (Fig. 3a) . During the next 24 h, RU 486 concentrations were maintained at 4 ng ml~T and the second injection of the drug, 24 h after the first, caused a further increase (P < 0.001) to 8.0 ng ml-1 within 15 min and a peak of 9 ng ml-1 by 45 min. RU 486 averaged 5 + 0.7 ng ml"1 at the time of induced parturition. (Garzo et al, 1988; Swahn et al, 1990 throughout the 5-day treatment (Li et al, 1991b) . Furthermore, intracerebroventricular infusion of RU 486 increased prolactin plasma concentration within 20 min in hysterectomized pigs (Li et al, 1992) , and it is known that prolactin is required for progesterone and relaxin secretion by ageing corpora lutea in this species (Li et al, 1989 (Wolf et al, 1988; Hill et al, 1990) . RU 486 inhibited placental protein synthesis within 6 h of in vitro incubation (Ogle, 1988) , and decreased human chorionic gonadotrophin (hCG) produc¬ tion by expiants of human trophoblast (Swahn et al, 1990) , as well as production of progesterone, hCG and oestrogen by dis¬ persed human syncytiotrophoblast (Bischof et al, 1986 (Gaillard et al, 1984; Healy et al, 1985; Heikinheimo et al, 1990 (Wolf et al, 1988; Hill et al, 1990 
